These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 9722896)
1. Radiotherapy omitted in the treatment of selected children under 3 years of age with stage III favorable histology Wilms tumor. Pachnis A; Pritchard J; Gaze M; Levitt G; Michalski A Med Pediatr Oncol; 1998 Sep; 31(3):150-2. PubMed ID: 9722896 [TBL] [Abstract][Full Text] [Related]
2. Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial. Pritchard-Jones K; Bergeron C; de Camargo B; van den Heuvel-Eibrink MM; Acha T; Godzinski J; Oldenburger F; Boccon-Gibod L; Leuschner I; Vujanic G; Sandstedt B; de Kraker J; van Tinteren H; Graf N; Lancet; 2015 Sep; 386(9999):1156-64. PubMed ID: 26164096 [TBL] [Abstract][Full Text] [Related]
3. Results of the United Kingdom Children's Cancer Study Group first Wilms' Tumor Study. Pritchard J; Imeson J; Barnes J; Cotterill S; Gough D; Marsden HB; Morris-Jones P; Pearson D J Clin Oncol; 1995 Jan; 13(1):124-33. PubMed ID: 7799012 [TBL] [Abstract][Full Text] [Related]
4. Doxorubicin for favorable histology, Stage II-III Wilms tumor: results from the National Wilms Tumor Studies. Breslow NE; Ou SS; Beckwith JB; Haase GM; Kalapurakal JA; Ritchey ML; Shamberger RC; Thomas PR; D'Angio GJ; Green DM Cancer; 2004 Sep; 101(5):1072-80. PubMed ID: 15329918 [TBL] [Abstract][Full Text] [Related]
5. Outcome of patients with stage III or inoperable WT treated on the second United Kingdom WT protocol (UKWT2); a United Kingdom Children's Cancer Study Group (UKCCSG) study. Grundy RG; Hutton C; Middleton H; Imeson J; Pritchard J; Kelsey A; Marsden HB; Vujanic GM; Taylor RE; Pediatr Blood Cancer; 2004 Apr; 42(4):311-9. PubMed ID: 14966826 [TBL] [Abstract][Full Text] [Related]
6. Abdominal irradiation in unilateral nephroblastoma and its impact on local control and survival. Flentje M; Weirich A; Graf N; Pötter R; Zimmerman H; Ludwig R Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):163-9. PubMed ID: 9422573 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of disease classified as stage III in Wilms tumor: a report from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP). Spreafico F; Gandola L; D'Angelo P; Terenziani M; Collini P; Bianchi M; Provenzi M; Indolfi P; Pession A; Nantron M; Di Cataldo A; Marchianò A; Catania S; Fossati Bellani F; Piva L; Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):348-54. PubMed ID: 21075548 [TBL] [Abstract][Full Text] [Related]
8. Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: a report from the National Wilms' Tumor Study Group. Green DM; Breslow NE; Beckwith JB; Finklestein JZ; Grundy PE; Thomas PR; Kim T; Shochat SJ; Haase GM; Ritchey ML; Kelalis PP; D'Angio GJ J Clin Oncol; 1998 Jan; 16(1):237-45. PubMed ID: 9440748 [TBL] [Abstract][Full Text] [Related]
9. Treatment of children with stage IV favorable histology Wilms tumor: a report from the National Wilms Tumor Study Group. Green DM; Breslow NE; Evans I; Moksness J; D'Angio GJ Med Pediatr Oncol; 1996 Mar; 26(3):147-52. PubMed ID: 8544795 [TBL] [Abstract][Full Text] [Related]
10. Older age is an adverse prognostic factor in stage I, favorable histology Wilms' tumor treated with vincristine monochemotherapy: a study by the United Kingdom Children's Cancer Study Group, Wilm's Tumor Working Group. Pritchard-Jones K; Kelsey A; Vujanic G; Imeson J; Hutton C; Mitchell C; ; J Clin Oncol; 2003 Sep; 21(17):3269-75. PubMed ID: 12947062 [TBL] [Abstract][Full Text] [Related]
11. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study. Tournade MF; Com-Nougué C; de Kraker J; Ludwig R; Rey A; Burgers JM; Sandstedt B; Godzinski J; Carli M; Potter R; Zucker JM; J Clin Oncol; 2001 Jan; 19(2):488-500. PubMed ID: 11208843 [TBL] [Abstract][Full Text] [Related]
12. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study. Dome JS; Cotton CA; Perlman EJ; Breslow NE; Kalapurakal JA; Ritchey ML; Grundy PE; Malogolowkin M; Beckwith JB; Shamberger RC; Haase GM; Coppes MJ; Coccia P; Kletzel M; Weetman RM; Donaldson M; Macklis RM; Green DM J Clin Oncol; 2006 May; 24(15):2352-8. PubMed ID: 16710034 [TBL] [Abstract][Full Text] [Related]
13. Is radiotherapy required in first-line treatment of stage I diffuse anaplastic Wilms tumor? A report of SIOP-RTSG, AIEOP, JWiTS, and UKCCSG. Fajardo RD; van den Heuvel-Eibrink MM; van Tinteren H; Spreafico F; Acha T; Bergeron C; de Camargo B; Oldenburger F; Rübe C; Oue T; Vokuhl C; de Krijger RR; Vujanic G; Sebire N; Coulomb-L'Hermine A; Collini P; Gandola L; Pritchard-Jones K; Graf N; Janssens GO; van Grotel M Pediatr Blood Cancer; 2020 Feb; 67(2):e28039. PubMed ID: 31625685 [TBL] [Abstract][Full Text] [Related]
14. Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532. Fernandez CV; Mullen EA; Chi YY; Ehrlich PF; Perlman EJ; Kalapurakal JA; Khanna G; Paulino AC; Hamilton TE; Gow KW; Tochner Z; Hoffer FA; Withycombe JS; Shamberger RC; Kim Y; Geller JI; Anderson JR; Grundy PE; Dome JS J Clin Oncol; 2018 Jan; 36(3):254-261. PubMed ID: 29211618 [TBL] [Abstract][Full Text] [Related]
15. Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 study. Daw NC; Chi YY; Kim Y; Mullen EA; Kalapurakal JA; Tian J; Khanna G; Geller JI; Perlman EJ; Ehrlich PF; Warwick AB; Grundy PE; Fernandez CV; Dome JS; Eur J Cancer; 2019 Sep; 118():58-66. PubMed ID: 31325873 [TBL] [Abstract][Full Text] [Related]
17. Outcome of patients with Stage II/favorable histology Wilms tumor with and without local tumor spill: a report from the National Wilms Tumor Study Group. Green DM; Breslow NE; D'Angio GJ; Malogolowkin MH; Ritchey ML; Evans AE; Beckwith JB; Perlman EJ; Shamberger RC; Peterson S; Grundy PE; Dome JS; Thomas PR; Kalapurakal JA Pediatr Blood Cancer; 2014 Jan; 61(1):134-9. PubMed ID: 24038736 [TBL] [Abstract][Full Text] [Related]
18. Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group. Malogolowkin M; Cotton CA; Green DM; Breslow NE; Perlman E; Miser J; Ritchey ML; Thomas PR; Grundy PE; D'Angio GJ; Beckwith JB; Shamberger RC; Haase GM; Donaldson M; Weetman R; Coppes MJ; Shearer P; Coccia P; Kletzel M; Macklis R; Tomlinson G; Huff V; Newbury R; Weeks D; Pediatr Blood Cancer; 2008 Feb; 50(2):236-41. PubMed ID: 17539021 [TBL] [Abstract][Full Text] [Related]
19. Nephron sparing surgery (NSS) for unilateral wilms tumor (UWT): the SIOP 2001 experience. Wilde JC; Aronson DC; Sznajder B; Van Tinteren H; Powis M; Okoye B; Cecchetto G; Audry G; Fuchs J; Schweinitz DV; Heij H; Graf N; Bergeron C; Pritchard-Jones K; Van Den Heuvel-Eibrink M; Carli M; Oldenburger F; Sandstedt B; De Kraker J; Godzinski J Pediatr Blood Cancer; 2014 Dec; 61(12):2175-9. PubMed ID: 25156758 [TBL] [Abstract][Full Text] [Related]
20. Repeat nephron-sparing surgery for children with bilateral Wilms tumor. Kieran K; Williams MA; McGregor LM; Dome JS; Krasin MJ; Davidoff AM J Pediatr Surg; 2014 Jan; 49(1):149-53. PubMed ID: 24439600 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]